Qube Research & Technologies (QRT)’s Stereotaxis STXS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio STXS Stock Details STXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.5K	Sell	28,015 -24,161	-46%	-$53K	﹤0.01%	3171
2025 Q4	$120K	Sell	52,176 -42,569	-45%	-$113K	﹤0.01%	3161
2025 Q3	$295K	Buy	+94,745	New	+$245K	﹤0.01%	2856
2024 Q2	–	Sell	-181,525	Closed	-$474K	–	4682
2024 Q1	$474K	Buy	181,525 +36,811	+25%	+$87.5K	﹤0.01%	2564
2023 Q4	$253K	Buy	144,714 +133,769	+1,222%	+$216K	﹤0.01%	2674
2023 Q3	$17.3K	Buy	+10,945	New	+$17.5K	﹤0.01%	3191
2023 Q2	–	Sell	-43,826	Closed	-$89.4K	–	2992
2023 Q1	$89.4K	Sell	43,826 -8,953	-17%	-$20.1K	﹤0.01%	2147
2022 Q4	$109K	Buy	52,779 +13,465	+34%	+$26.3K	﹤0.01%	1985
2022 Q3	$71K	Sell	39,314 -7,477	-16%	-$16K	﹤0.01%	2065
2022 Q2	$86K	Buy	+46,791	New	+$112K	﹤0.01%	1989

Other funds holding STXS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s STXS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Stereotaxis (STXS) stake by 46% in Q1 2026, selling an estimated $53K and leaving 28,015 shares worth $51.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

Qube Research & Technologies (QRT) first reported a position in STXS in Q2 2022 and has held it in 10 quarters since. The position peaked at $474K in Q1 2024. 115 funds tracked by Wall St. Rank hold STXS as of Q1 2026.

Qube Research & Technologies (QRT) held 28,015 shares of Stereotaxis worth $51.5K as of Q1 2026.
Qube Research & Technologies (QRT) sold 24,161 Stereotaxis shares in Q1 2026, an estimated $53K.
Stereotaxis made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3171 holding.
Qube Research & Technologies (QRT) first reported a position in Stereotaxis in Q2 2022 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Stereotaxis position peaked at $474K in Q1 2024.
115 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.